Skip to main content

Table 5 Patient characteristics on admission by prognostic outcome

From: Non-HIV Pneumocystis pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity?

Item Survivors (n = 13) Non-survivors (n = 8) p
Age 69.4 (8.9) 74.9 (9.3) 0.193
BMI (kg/m2) 22.3 (3.5) 22.5 (1.7) 0.872
β-DG (pg/ml) 93.8 (161) 82 (64.2) 0.846
KL-6 (U/ml) 771 (461) 1588 (1417) 0.104
LDH (IU/l) 521 (276) 799 (329) 0.051
CRP (mg/dl) 8.22 (4.35) 9.62 (4.92) 0.502
Alb/BUN 0.211 (0.133) 0.119 (0.054) 0.078
Lymphocytes (/μl) 1203 (1011) 752 (389) 0.28
Neutrophils (/μl) 7181 (3012) 7511 (3083) 0.825
WBC (/μl) 9323 (3581) 8700 (3103) 0.7
Interval from admission to PCP diagnosis (days)  
  4 (2.83) 7.88 (3.56) 0.012
Interval from admission to start PCP-specific treatment (days)  
  1.77 (2.74) 6.88 (4.67) 0.005